Literature DB >> 10403478

Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry.

R Würzner1.   

Abstract

Most pathogens invading the human body are attacked by the host immune system directly following entry and usually also during most stages of the disease, especially when they are in contact with the blood. However, pathogens have developed an effective battery of specific strategies to overcome immune defense. This, far from being complete, review concentrates on evasion of pathogens by avoiding recognition or eradication by complement. The latter is achieved by removal of complement either by shedding it off the microbial surface, by consuming it away from the target membrane or by destroying it. Alternative procedures of avoiding eradication are the inhibition of complement activation or the employment of complement proteins via several highly sophisticated mechanisms, including the imitation of complement-like proteins (molecular mimicry).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403478     DOI: 10.1016/s0161-5890(99)00049-8

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  19 in total

Review 1.  Modulation of complement membrane attack by local C7 synthesis.

Authors:  R Würzner
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

2.  Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes.

Authors:  B A Fernie-King; D J Seilly; C Willers; R Würzner; A Davies; P J Lachmann
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

Review 3.  Deficiencies of the complement MAC II gene cluster (C6, C7, C9): is subtotal C6 deficiency of particular evolutionary benefit?

Authors:  R Würzner
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

4.  EspP, a serine protease of enterohemorrhagic Escherichia coli, impairs complement activation by cleaving complement factors C3/C3b and C5.

Authors:  Dorothea Orth; Silvia Ehrlenbach; Jens Brockmeyer; Abdul Basit Khan; Georg Huber; Helge Karch; Bettina Sarg; Herbert Lindner; Reinhard Würzner
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

5.  Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis.

Authors:  C M Fernandez-Prada; M Nikolich; R Vemulapalli; N Sriranganathan; S M Boyle; G G Schurig; T L Hadfield; D L Hoover
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 6.  The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women.

Authors:  Jennifer L Edwards; Michael A Apicella
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Killing of Gram-negative bacteria with normal human serum and normal bovine serum: use of lysozyme and complement proteins in the death of Salmonella strains O48.

Authors:  G Bugla-Płoskońska; A Kiersnowski; B Futoma-Kołoch; W Doroszkiewicz
Journal:  Microb Ecol       Date:  2009-03-18       Impact factor: 4.552

8.  Herpes simplex virus 1 infected neuronal and skin cells differ in their susceptibility to complement attack.

Authors:  Riina Rautemaa; Tuula Helander; Seppo Meri
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

Review 9.  Factor H and neisserial pathogenesis.

Authors:  Jo Anne Welsch; Sanjay Ram
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

10.  Bordetella pertussis acquires resistance to complement-mediated killing in vivo.

Authors:  Elizabeth J Pishko; David J Betting; Christina S Hutter; Eric T Harvill
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.